2001
Linezolid and Reversible Myelosuppression
Search citation statements
Paper Sections
Select...
148
36
11
6
Citation Types
7
112
0
5
Year Published
2001
2026
Publication Types
Select...
171
11
6
2
Relationship
0
190
Authors
Journals
Cited by 190 publications
(124 citation statements)
References 0 publications
7
112
0
5
“……”
Section: Discussionsupporting
confidence: 93%
“……”
Section: Discussionsupporting
confidence: 93%
“…Although the mechanisms underlying LZD‐induced cytopenia (e.g., thrombocytopenia, leukopenia, and anemia) are not clear, our case was consistent with more recent reports of chloramphenicol‐like toxicity . Oxazolidinones represent a novel class of synthetic antimicrobial agents, with a unique mechanism of inhibiting protein synthesis .…”
Section: Discussionsupporting
confidence: 90%
“…These results were in good agreement with the timing of the platelet count nadir previously described as non‐immune‐mediated thrombocytopenia (PDI) and immune‐mediated thrombocytopenia (PDS) . In view of these results, we recommend that platelet count monitoring should be considered for all patients immediately before the start of linezolid treatment, and then on days 2 and 4 and weeks 1, 2 and 3.…”
Section: Discussionsupporting
confidence: 88%
